Company profile for Celid Biotechnologies

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CELiD Biotechnologies Inc. (CBI), is dedicated to the production and development of CELiD vector DNA (ceDNA) and adeno-associated virus (AAV) to treat metabolic liver disease and hemophilia. CBI holds licensing rights to this technology from the National Institutes of Health. CELiD Biotechnologies Inc. is aiming to develop a new generation of AAV-like, non-viral gene therapy medicines for genetic metabolic disorders, such as ...
CELiD Biotechnologies Inc. (CBI), is dedicated to the production and development of CELiD vector DNA (ceDNA) and adeno-associated virus (AAV) to treat metabolic liver disease and hemophilia. CBI holds licensing rights to this technology from the National Institutes of Health. CELiD Biotechnologies Inc. is aiming to develop a new generation of AAV-like, non-viral gene therapy medicines for genetic metabolic disorders, such as methylmalonic acidemia (MMA) and rare diseases, such as hemophilia A, which are caused by inherited genetic mutations

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
​12211 Parklawn Dr. Rockville, MD 20850
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty